MasterPharm LLC is recalling approximately 52,240 units of various compounded medications, including hair loss treatments, hormone therapies, and performance medications, due to a lack of processing controls. This defect means there is no assurance that the drugs meet their intended specifications for quality and potency. The recall affects a wide range of products including Minoxidil, Progesterone, Tadalafil, and Sildenafil in various forms like capsules, tablets, and troches (lozenges) distributed nationwide.
A lack of processing controls can result in medications that are either too weak to be effective or too strong, potentially leading to unexpected side effects or therapeutic failure. While no specific injuries were reported in this notice, improper dosing of hormones or cardiovascular medications poses a moderate risk to patient health.
Contact pharmacy for return and refund information.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.